Products in Development
Evofem Biosciences® is dedicated to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Evofem is leveraging its proprietary vaginal pH modulator to develop product candidates for multiple indications, including the prevention of urogenital transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis.
EVO100 – an investigational candidate for the prevention of urogenital chlamydia and gonorrhea in women
It is designed to reduce certain vaginal infections by:
- Balancing vaginal pH, thereby maintaining healthy vaginal flora and creating an environment that is detrimental to the growth and proliferation of harmful bacteria
- Using a different mechanism of action that may help to address drug resistance concerns
Vaginal pH modulator for the prevention of recurrent Bacterial Vaginosis (BV)
- Kill many BV-associated pathogenic bacteria which has been demonstrated in vitro
- Balance vaginal pH, thereby supporting normal vaginal flora and eliminating odor associated with BV
These products have not been approved for marketing by the U.S. Food and Drug Administration or any other regulatory agency.